Literature DB >> 16964510

Prospective controlled study of the diagnostic value of skin biopsy in patients with presumed meningococcal disease.

S M Arend1, A P M Lavrijsen, I Kuijken, R N van der Plas, E J Kuijper.   

Abstract

Microbiological tests for diagnosis of acute meningococcal disease are important for the clinical management of patients with this often-fatal illness, but cultures are frequently negative after antibiotics have been administered. Retrospective studies suggest that examination of skin biopsies may aid a rapid diagnosis and that cultures of skin biopsies are often positive even after antimicrobial treatment has commenced. This prospective controlled study aimed to assess the diagnostic value of skin biopsy compared with investigations of blood and cerebrospinal fluid (CSF) in patients with skin lesions and presumed meningococcal disease. A total of 43 patients, 31 with suspected acute meningococcal infection and 12 controls, were included. All skin biopsies were investigated by Gram stain and routine microbiological culture. In 25 patients, meningococcal infection was diagnosed microbiologically. The clinical diagnosis was meningococcal meningitis in 8 patients, meningococcal sepsis in 11 patients, and a combination of both in 6 patients. The sensitivity of cultures of blood, CSF, and skin biopsies was 56%, 50%, and 36%, respectively. When culture and Gram stain were combined, positive results were obtained in 56%, 64%, and 56%, respectively. There was no correlation between the diagnostic yield of skin biopsies and previous antibiotic treatment. In 14 patients, the diagnosis was based exclusively on one positive sample: CSF in 7 (28%) patients, blood in 4 (16%) patients, and skin biopsy in 3 (12%) patients. The sensitivity of skin biopsies was highest in patients with the least extensive skin lesions. Specificity was 100%. Microbiological investigation of skin biopsies increased the diagnostic yield and could be considered a component of the routine diagnostic work-up in patients with suspected meningococcal infection, even after the initiation of antimicrobial treatment.

Entities:  

Mesh:

Year:  2006        PMID: 16964510     DOI: 10.1007/s10096-006-0199-7

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  10 in total

Review 1.  Meningococcal disease.

Authors:  N E Rosenstein; B A Perkins; D S Stephens; T Popovic; J M Hughes
Journal:  N Engl J Med       Date:  2001-05-03       Impact factor: 91.245

2.  Analysis of pathogen-host cell interactions in purpura fulminans: expression of capsule, type IV pili, and PorA by Neisseria meningitidis in vivo.

Authors:  O B Harrison; B D Robertson; S N Faust; M A Jepson; R D Goldin; M Levin; R S Heyderman
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

3.  Avoidable deficiencies in the delivery of health care to children with meningococcal disease.

Authors:  S Nadel; J Britto; R Booy; I Maconochie; P Habibi; M Levin
Journal:  J Accid Emerg Med       Date:  1998-09

Review 4.  Update on meningococcal disease with emphasis on pathogenesis and clinical management.

Authors:  M van Deuren; P Brandtzaeg; J W van der Meer
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

5.  The usefulness of skin culture in the diagnosis of chronic meningococcaemia.

Authors:  M Texereau; P Roblot; A Dumars; B Grignon; B Becq-Giraudon
Journal:  J Intern Med       Date:  1997-12       Impact factor: 8.989

6.  Pathogenesis and diagnosis of human meningococcal disease using immunohistochemical and PCR assays.

Authors:  Jeannette Guarner; Patricia W Greer; Anne Whitney; Wun-Ju Shieh; Marc Fischer; Elizabeth H White; George M Carlone; David S Stephens; Tanja Popovic; Sherif R Zaki
Journal:  Am J Clin Pathol       Date:  2004-11       Impact factor: 2.493

7.  Evaluation of touch-down real-time PCR based on SYBR Green I fluorescent dye for the detection of Neisseria meningitidis in clinical samples.

Authors:  Konstantinos Kesanopoulos; Georgina Tzanakaki; Stamatina Levidiotou; Caroline Blackwell; Jenny Kremastinou
Journal:  FEMS Immunol Med Microbiol       Date:  2005-03-01

8.  Rapid diagnosis of acute meningococcal infections by needle aspiration or biopsy of skin lesions.

Authors:  M van Deuren; B J van Dijke; R J Koopman; A M Horrevorts; J F Meis; F W Santman; J W van der Meer
Journal:  BMJ       Date:  1993-05-08

9.  Rapid detection of meningococci from petechiae in acute meningococcal infection.

Authors:  M Periappuram; M R Taylor; C T Keane
Journal:  J Infect       Date:  1995-11       Impact factor: 6.072

Review 10.  Steroids in adults with acute bacterial meningitis: a systematic review.

Authors:  Diederik van de Beek; Jan de Gans; Peter McIntyre; Kameshwar Prasad
Journal:  Lancet Infect Dis       Date:  2004-03       Impact factor: 25.071

  10 in total
  4 in total

Review 1.  Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis.

Authors:  Matthijs C Brouwer; Allan R Tunkel; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

Review 2.  Skin and sepsis: contribution of dermatology to a rapid diagnosis.

Authors:  A Pulido-Pérez; E Bouza; M Bergón-Sendín; R Suárez-Fernández; P Muñoz-Martín
Journal:  Infection       Date:  2021-04-15       Impact factor: 3.553

Review 3.  Cutaneous Manifestations Related to COVID-19 Immune Dysregulation in the Pediatric Age Group.

Authors:  Désirée Larenas-Linnemann; Jorge Luna-Pech; Elsy M Navarrete-Rodríguez; Noel Rodríguez-Pérez; Alfredo Arias-Cruz; María Virginia Blandón-Vijil; Blanca E Del Rio-Navarro; Alan Estrada-Cardona; Ernesto Onuma-Takane; Cesar Fireth Pozo-Beltrán; Adriana María Valencia-Herrera; Francisco Ignacio Ortiz-Aldana; Mirna Eréndira Toledo-Bahena
Journal:  Curr Allergy Asthma Rep       Date:  2021-02-25       Impact factor: 4.806

Review 4.  Management of Infectious Emergencies for the Inpatient Dermatologist.

Authors:  Tulsi Patel; Krystina Quow; Adela R Cardones
Journal:  Curr Dermatol Rep       Date:  2021-10-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.